Literature DB >> 31419564

Tissue-engineered 3D models for elucidating primary and metastatic bone cancer progression.

Eva C González Díaz1, Sauradeep Sinha1, Raffi S Avedian2, Fan Yang3.   

Abstract

Malignant bone tumors are aggressive neoplasms which arise from bone tissue or as a result of metastasis. The most prevalent types of cancer, such as breast, prostate, and lung cancer, all preferentially metastasize to bone, yet the role of the bone niche in promoting cancer progression remains poorly understood. Tissue engineering has the potential to bridge this knowledge gap by providing 3D in vitro systems that can be specifically designed to mimic key properties of the bone niche in a more physiologically relevant context than standard 2D culture. Elucidating the crucial components of the bone niche that recruit metastatic cells, support tumor growth, and promote cancer-induced destruction of bone tissue would support efforts for preventing and treating these devastating malignancies. In this review, we summarize recent efforts focused on developing in vitro 3D models of primary bone cancer and bone metastasis using tissue engineering approaches. Such 3D in vitro models can enable the identification of effective therapeutic targets and facilitate high-throughput drug screening to effectively treat bone cancers. STATEMENT OF SIGNIFICANCE: Biomaterials-based 3D culture have been traditionally used for tissue regeneration. Recent research harnessed biomaterials to create 3D in vitro cancer models, with demonstrated advantages over conventional 2D culture in recapitulating tumor progression and drug response in vivo. However, previous work has been largely limited to modeling soft tissue cancer, such as breast cancer and brain cancer. Unlike soft tissues, bone is characterized with high stiffness and mineral content. Primary bone cancer affects mostly children with poor treatment outcomes, and bone is the most common site of cancer metastasis. Here we summarize emerging efforts on engineering 3D bone cancer models using tissue engineering approaches, and future directions needed to further advance this relatively new research area.
Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomaterials; Bone cancer; Bone metastasis; Tissue engineering

Mesh:

Substances:

Year:  2019        PMID: 31419564      PMCID: PMC8697422          DOI: 10.1016/j.actbio.2019.08.020

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  117 in total

1.  Nanoparticle-mediated siRNA delivery assessed in a 3D co-culture model simulating prostate cancer bone metastasis.

Authors:  Kathleen A Fitzgerald; Jianfeng Guo; Rosanne M Raftery; Irene Mencía Castaño; Caroline M Curtin; Matt Gooding; Raphael Darcy; Fergal J O' Brien; Caitriona M O' Driscoll
Journal:  Int J Pharm       Date:  2016-08-01       Impact factor: 5.875

2.  Three-dimensional porous silk tumor constructs in the approximation of in vivo osteosarcoma physiology.

Authors:  Pamela H S Tan; K Z Aung; S L Toh; James C H Goh; S S Nathan
Journal:  Biomaterials       Date:  2011-05-31       Impact factor: 12.479

3.  Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid.

Authors:  Sara Pedron; Eftalda Becka; Brendan A C Harley
Journal:  Biomaterials       Date:  2013-07-01       Impact factor: 12.479

4.  Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease.

Authors:  Xu Feng
Journal:  Curr Chem Biol       Date:  2009-05-01

5.  Pericellular matrix formation alters the efficiency of intracellular uptake of oligonucleotides in osteosarcoma cells.

Authors:  Yoshitaka Suzuki; Yoshihiro Nishida; Takahiro Naruse; Takefumi Gemba; Naoki Ishiguro
Journal:  J Surg Res       Date:  2008-03-26       Impact factor: 2.192

6.  Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.

Authors:  V Sung; J T Stubbs; L Fisher; A D Aaron; E W Thompson
Journal:  J Cell Physiol       Date:  1998-09       Impact factor: 6.384

7.  Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells.

Authors:  Hassan Adwan; Tobias Bäuerle; Yousef Najajreh; Victoria Elazer; Gershon Golomb; Martin R Berger
Journal:  Int J Oncol       Date:  2004-05       Impact factor: 5.650

Review 8.  Anti-angiogenesis target therapy for advanced osteosarcoma (Review).

Authors:  Lu Xie; Tao Ji; Wei Guo
Journal:  Oncol Rep       Date:  2017-06-21       Impact factor: 3.906

9.  Establishment of a human 3D lung cancer model based on a biological tissue matrix combined with a Boolean in silico model.

Authors:  Anna T Stratmann; David Fecher; Gaby Wangorsch; Claudia Göttlich; Thorsten Walles; Heike Walles; Thomas Dandekar; Gudrun Dandekar; Sarah L Nietzer
Journal:  Mol Oncol       Date:  2013-12-18       Impact factor: 6.603

Review 10.  The complexity of integrins in cancer and new scopes for therapeutic targeting.

Authors:  Hellyeh Hamidi; Mika Pietilä; Johanna Ivaska
Journal:  Br J Cancer       Date:  2016-09-29       Impact factor: 7.640

View more
  5 in total

1.  A 3D-printed scaffold-based osteosarcoma model allows to investigate tumor phenotypes and pathogenesis in an in vitro bone-mimicking niche.

Authors:  Mei-Ling Wang; Nian-Yuan Xu; Rui-Zhi Tang; Xi-Qiu Liu
Journal:  Mater Today Bio       Date:  2022-05-25

2.  Breast cancer-secreted factors perturb murine bone growth in regions prone to metastasis.

Authors:  Aaron E Chiou; Chuang Liu; Inés Moreno-Jiménez; Tengteng Tang; Wolfgang Wagermaier; Mason N Dean; Claudia Fischbach; Peter Fratzl
Journal:  Sci Adv       Date:  2021-03-17       Impact factor: 14.136

Review 3.  3D Printing and Bioprinting to Model Bone Cancer: The Role of Materials and Nanoscale Cues in Directing Cell Behavior.

Authors:  Tiziana Fischetti; Gemma Di Pompo; Nicola Baldini; Sofia Avnet; Gabriela Graziani
Journal:  Cancers (Basel)       Date:  2021-08-12       Impact factor: 6.639

Review 4.  Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment.

Authors:  Nan Sethakorn; Erika Heninger; Cristina Sánchez-de-Diego; Adeline B Ding; Ravi Chandra Yada; Sheena C Kerr; David Kosoff; David J Beebe; Joshua M Lang
Journal:  Cancers (Basel)       Date:  2022-02-01       Impact factor: 6.639

5.  Identification and validation of a cigarette smoke-related five-gene signature as a prognostic biomarker in kidney renal clear cell carcinoma.

Authors:  Yefei Huang; Qinzhi Wang; Yu Tang; Zixuan Liu; Guixiang Sun; Zhaojun Lu; Yansu Chen
Journal:  Sci Rep       Date:  2022-02-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.